Association Between Baseline Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Death Among Patients Tested for COVID-19
Sarah A. Thomas, Michael Puskarich, Michael S. Pulia, Andrew C. Meltzer, Carlos A. Camargo, D. Mark Courtney, Kristen E. Nordenholz, Jeffrey A. Kline, Christopher Kabrhel
Dive into the research topics of 'Association Between Baseline Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Death Among Patients Tested for COVID-19'. Together they form a unique fingerprint.